Guanfacine Hydrochloride Patent Expiration

Guanfacine Hydrochloride is Used for treating attention-deficit hyperactivity disorder. It was first introduced by Promius Pharma Llc in its drug Tenex on Oct 27, 1986. Another drug containing Guanfacine Hydrochloride is Intuniv. 22 different companies have introduced drugs containing Guanfacine Hydrochloride.


Guanfacine Hydrochloride Patents

Given below is the list of patents protecting Guanfacine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Intuniv US5854290 Use of guanfacine in the treatment of behavioral disorders Sep 21, 2015

(Expired)

Takeda Pharms Usa
Intuniv US5854290

(Pediatric)

Use of guanfacine in the treatment of behavioral disorders Mar 21, 2016

(Expired)

Takeda Pharms Usa
Intuniv US6287599 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Dec 20, 2020

(Expired)

Takeda Pharms Usa
Intuniv US6287599

(Pediatric)

Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Jun 20, 2021

(Expired)

Takeda Pharms Usa
Intuniv US6811794 Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Jul 04, 2022

(Expired)

Takeda Pharms Usa
Intuniv US6811794

(Pediatric)

Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Jan 04, 2023

(Expired)

Takeda Pharms Usa


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Guanfacine Hydrochloride Generics

Several generic applications have been filed for Guanfacine Hydrochloride. The first generic version for Guanfacine Hydrochloride was by Watson Laboratories Inc and was approved on Oct 17, 1995. And the latest generic version is by Wanbang Biopharmaceuticals and was approved on Jun 12, 2024.

Given below is the list of companies who have filed for Guanfacine Hydrochloride generic.


1. WANBANG BIOPHARMS

Wanbang Biopharmaceuticals has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Wanbang Biopharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet, extended release Prescription ORAL AB Jun 12, 2024
EQ 2MG BASE tablet, extended release Prescription ORAL AB Jun 12, 2024
EQ 3MG BASE tablet, extended release Prescription ORAL AB Jun 12, 2024
EQ 4MG BASE tablet, extended release Prescription ORAL AB Jun 12, 2024


2. UNICHEM

Unichem Laboratories Ltd has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE tablet Prescription ORAL AB Mar 3, 2021
EQ 1MG BASE tablet Prescription ORAL AB Mar 3, 2021


3. APOTEX

Apotex Inc has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet, extended release Prescription ORAL AB Jul 25, 2018
EQ 4MG BASE tablet, extended release Prescription ORAL AB Jul 25, 2018
EQ 3MG BASE tablet, extended release Prescription ORAL AB Jul 25, 2018
EQ 2MG BASE tablet, extended release Prescription ORAL AB Jul 25, 2018


4. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE tablet, extended release Prescription ORAL AB Aug 7, 2023
EQ 2MG BASE tablet, extended release Prescription ORAL AB Aug 7, 2023
EQ 3MG BASE tablet, extended release Prescription ORAL AB Aug 7, 2023
EQ 1MG BASE tablet, extended release Prescription ORAL AB Aug 7, 2023


5. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet, extended release Prescription ORAL AB Jun 2, 2015
EQ 2MG BASE tablet, extended release Prescription ORAL AB Jun 2, 2015
EQ 3MG BASE tablet, extended release Prescription ORAL AB Jun 2, 2015
EQ 4MG BASE tablet, extended release Prescription ORAL AB Jun 2, 2015


6. AMNEAL PHARM

Amneal Pharmaceutical has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE

(reference standard)

tablet Prescription ORAL AB Nov 25, 1998
EQ 1MG BASE tablet Prescription ORAL AB Nov 25, 1998


7. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet Discontinued ORAL N/A Jun 25, 1997
EQ 2MG BASE tablet Discontinued ORAL N/A Jun 25, 1997


8. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet, extended release Prescription ORAL AB Oct 5, 2012
EQ 2MG BASE tablet, extended release Prescription ORAL AB Oct 5, 2012
EQ 3MG BASE tablet, extended release Prescription ORAL AB Oct 5, 2012
EQ 4MG BASE tablet, extended release Prescription ORAL AB Oct 5, 2012


9. TWI PHARMS

Twi Pharmaceuticals Inc has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Twi Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet Prescription ORAL AB Jun 8, 2022
EQ 2MG BASE tablet Prescription ORAL AB Jun 8, 2022
EQ 3MG BASE tablet, extended release Prescription ORAL AB Jun 2, 2015
EQ 4MG BASE tablet, extended release Prescription ORAL AB Jun 2, 2015


10. AUROBINDO PHARMA USA

Aurobindo Pharma Usa Inc has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE tablet Prescription ORAL AB Jan 27, 1997
EQ 1MG BASE tablet Prescription ORAL AB Jan 27, 1997


11. XIROMED

Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Xiromed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet Prescription ORAL AB Feb 23, 2024
EQ 2MG BASE tablet Prescription ORAL AB Feb 23, 2024


12. SANDOZ

Sandoz Inc has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE tablet, extended release Prescription ORAL AB Jun 3, 2015
EQ 1MG BASE tablet, extended release Prescription ORAL AB Jun 3, 2015
EQ 2MG BASE tablet, extended release Prescription ORAL AB Jun 3, 2015
EQ 3MG BASE tablet, extended release Prescription ORAL AB Jun 3, 2015


13. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet Prescription ORAL AB Apr 27, 2023
EQ 2MG BASE tablet Prescription ORAL AB Apr 27, 2023


14. I 3 PHARMS

I 3 Pharmaceuticals Llc has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by I 3 Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE tablet Prescription ORAL AB Oct 5, 2023
EQ 1MG BASE tablet Prescription ORAL AB Oct 5, 2023


15. IMPAX LABS INC

Impax Laboratories Inc has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE tablet, extended release Discontinued ORAL N/A Oct 20, 2015
EQ 3MG BASE tablet, extended release Discontinued ORAL N/A Oct 20, 2015
EQ 2MG BASE tablet, extended release Discontinued ORAL N/A Oct 20, 2015
EQ 1MG BASE tablet, extended release Discontinued ORAL N/A Oct 20, 2015


16. RUBICON

Rubicon Research Private Ltd has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 1MG BASE tablet Prescription ORAL AB Oct 17, 2023
EQ 2MG BASE tablet Prescription ORAL AB Oct 17, 2023


17. MYLAN

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 4MG BASE tablet, extended release Discontinued ORAL N/A Jun 2, 2015
EQ 3MG BASE tablet, extended release Discontinued ORAL N/A Jun 2, 2015
EQ 1MG BASE tablet, extended release Discontinued ORAL N/A Jun 2, 2015
EQ 2MG BASE tablet, extended release Discontinued ORAL N/A Jun 2, 2015


18. YICHANG HUMANWELL

Yichang Humanwell Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Yichang Humanwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE tablet, extended release Prescription ORAL AB Nov 25, 2020
EQ 1MG BASE tablet, extended release Prescription ORAL AB Nov 25, 2020
EQ 4MG BASE tablet, extended release Prescription ORAL AB Nov 25, 2020
EQ 3MG BASE tablet, extended release Prescription ORAL AB Nov 25, 2020


19. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE tablet, extended release Prescription ORAL AB Nov 16, 2017
EQ 1MG BASE tablet, extended release Prescription ORAL AB Nov 16, 2017
EQ 3MG BASE tablet, extended release Prescription ORAL AB Nov 16, 2017
EQ 4MG BASE tablet, extended release Prescription ORAL AB Nov 16, 2017


20. EPIC PHARMA LLC

Epic Pharma Llc has filed for 2 different strengths of generic version for Guanfacine Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
EQ 2MG BASE tablet Prescription ORAL AB Feb 28, 1997
EQ 1MG BASE tablet Prescription ORAL AB Feb 28, 1997